Continuous and long-term treatment is more important than dosage for the protective effect of thiazide use on bone metabolism and fracture risk

Journal of Internal Medicine

Volumn 279, Issue 1, 2016, Pages 110-122

  Kruse, C ^a   Eiken, P ^b,c   Vestergaard, P ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bone metabolism; Diuretics; Fractures; Osteoporosis; Thiazides

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARBAMAZEPINE; COBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLUCOCORTICOID; HALOPERIDOL; INSULIN; LAMOTRIGINE; LITHIUM; POTASSIUM; RISPERIDONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; THIAZIDE DIURETIC AGENT; THYROID HORMONE; VERAPAMIL;

AGED; ALCOHOL LIVER DISEASE; ARM FRACTURE; ARTICLE; BONE METABOLISM; CEREBROVASCULAR ACCIDENT; CHARLSON COMORBIDITY INDEX; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG EXPOSURE; FEMALE; FEMUR FRACTURE; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOGONADISM; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MINERAL SUPPLEMENTATION; NEOPLASM; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PARKINSON DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL STATUS; SPINE FRACTURE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WRIST FRACTURE; BONE; DATA BASE; DRUG EFFECTS; FRACTURES, BONE; METABOLISM; RETROSPECTIVE STUDY;

AGED; BONE AND BONES; COHORT STUDIES; COMORBIDITY; DATABASES AS TOPIC; FEMALE; FRACTURES, BONE; HUMANS; MALE; RETROSPECTIVE STUDIES; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84949591277     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12397     Document Type: Article

References (14)

1. Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst Rev 2011; CD005195.
2. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006; 119: 71.e1-8.
3. Bolland MJ, Ames RW, Horne AM, Orr-walker BJ, Gamble GD, Reid IR. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 2007; 18: 479-86.
4. Lacroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 133: 516-26.
5. Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L. Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women. Eur J Clin Invest 2003; 33: 41-50.
6. Statistics Denmark, http://www.dst.dk/da/Statistik/emner/befolkning-og-befolkningsfremskrivning/folketal.aspx
7. Own data. 7.3 million C03AB prescriptions vs. 87, 000 C03AA prescriptions between 1996 and 2011.
8. Transbøl I, Christensen MS, Jensen GF, Christiansen C, Mcnair P. Thiazide for the postponement of postmenopausal bone loss. Metab, Clin Exp 1982; 31: 383-6.
9. Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y. Diuretic initiation and the acute risk of hip fracture. Osteoporos Int 2013; 24: 689-95.
10. Reid IR, Ames RW, Orr-walker BJ et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 2000; 109: 362-70.
11. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res 2006; 21: 163-70.
12. Reusz GS, Dobos M, Vásárhelyi B et al. Sodium transport and bone mineral density in hypercalciuria with thiazide treatment. Pediatr Nephrol 1998; 12: 30-4.
13. Vestergaard P, Mosekilde L. Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16, 416 patients in Denmark. Am J Epidemiol 2002; 156: 1-10.
14. Mosbech J, Jørgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD. [Landspatientregisteret. Evaluering af datakvaliteten.]. Dan Med J 1995; 157: 3741-5.